Contributor
Nigel Rawson is an independent researcher in Saskatoon and an affiliate scholar with the Canadian Health Policy Institute.
For many Canadians, important pharmaceuticals are too expensive. But initiatives by the Trudeau government and a federal regulator to combat this problem won't help Canadians access new, life-saving, but costly medicines. Just the opposite.